Allergan Announces New Board Member; Prof. Trevor M. Jones Appointed.IRVINE, Calif. -- Allergan, Inc. (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) today announced the appointment of Prof. Trevor M. Jones to the Company's Board of Directors. Prof. Jones is the current Director General of the Association of the British Pharmaceutical Industry The Association of the British Pharmaceutical Industry (ABPI) is the trade association for companies in the UK producing prescription medicines. This is the British equivalent of PhRMA, however the member companies research, develop, manufacture and supply medicines prescribed (ABPI ABPI Association of the British Pharmaceutical Industry ABPI Associação Brasileira da Propriedade Intelectual (Brazilian Intellectual Property Association; Brazil) ABPI Ankle Brachial Pressure Index ), an association representing the interests of approximately 100 British and international pharmaceutical companies. From 1987 to 1994, Prof. Jones was the main board director at Wellcome where he was responsible for all research and development activities. At Wellcome, Prof. Jones led the successful development of numerous pharmaceutical compounds, as well as a number of over-the-counter medicines. "Prof. Jones' extensive expertise in research and development, and experience in the European and global pharmaceutical industry, make him an outstanding addition to Allergan's Board of Directors," said David E.I. Pyott, Allergan's Chairman of the Board, President and Chief Executive Officer. "We expect that Prof. Jones' breadth and depth of global experience with the important issues that face this industry will be instrumental in guiding our future strategies." Prof. Jones received his bachelor of pharmacy A Bachelor of Pharmacy (abbreviated BPharm) is an undergraduate academic degree in the field of pharmacy. The degree is a basic prerequisite, in many countries, for registration to practice as a pharmacist. degree and Ph.D. from the University of London For most practical purposes, ranging from admission of students to negotiating funding from the government, the 19 constituent colleges are treated as individual universities. Within the university federation they are known as Recognised Bodies . He has also gained an honorary doctorate from the University of Athens as well as honorary doctorates in science from the Universities of Strathclyde, Nottingham, Bath and Bradford in the United Kingdom. Furthermore, he was recognized in the Queen's Honors List and holds the title of a Commander of the British Empire. He is also a fellow of the Royal Society Fellow of the Royal Society is an honour accorded to distinguished scientists and a category of membership of the Royal Society. Fellows are entitled to put the letters FRS after their name. Up to 44 new fellows are elected each year by ballot of the existing fellows. of Chemistry, a fellow of The Pharmaceutical Society, and an honorary fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians The Royal College of Physicians of London was the first medical institution in England to receive a Royal Charter. It was founded in 1518 and is one of the most active of all medical professional organisations. . About Allergan, Inc. Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company providing specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator, skin care and other specialty markets that deliver value to its customers, satisfy unmet medical needs, and improve patients' lives. Forward-Looking Statements Statements regarding future plans, forecasts, and events are "forward-looking statements." These statements are based on current expectations and intentions only. If underlying assumptions prove inaccurate, or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations. Information concerning risk factors can be found in press releases issued by Allergan as well as Allergan's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Certain Factors and Trends Affecting Allergan and its Businesses" in Allergan's 2003 Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and its Form 10-Q for the quarter ended March 26, 2004. Copies of Allergan's press releases and additional information about Allergan are available on the World Wide Web at www.allergan.com, or you can contact the Allergan Investor Relations Department by calling 1-714-246-4636. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion